MMED MiniMed Group, Inc. - Common Stock
$15.59
Price · Jul 2, 2026
Fundamentals as of Jun 29, 2026
52W Range
$11–$16
96% of range
Analyst Rating
BUY
15 analysts
Price Target
$21
+34% upside
P/E (TTM)
-10.2
ROE
-9.3%
Net Profit Margin
-10.7%
MMED Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$15.59
Market Cap
$3.71B
P/E (TTM)
-10.2
EPS (TTM)
$-1.30
Revenue (TTM)
$3.10B
Div Yield
—
ROE
-9.3%
Debt/Equity
—
52W Range
$11 – $16
MMED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$3.10B
2024-04-26
→
2026-04-24
EPS
$-1.30
2024-04-26
→
2026-04-24
Free Cash Flow
$-420M
2026-04-24
→
2026-04-24
Margins
-10.7%
2026-04-24
→
2026-04-24
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
MMED
Peer Median
P/E (TTM)
-10.2
—
P/S (TTM)
1.2
—
P/B
1.0
—
Price / FCF
-8.8
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
MMED
Peer Median
Gross Margin
54.2%
—
Operating Margin
-6.1%
—
Net Profit Margin
-10.7%
—
ROA
-7.5%
—
ROE
-9.3%
—
ROIC
-8.8%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
MMED
Peer Median
Current Ratio
1.9
—
Quick Ratio
0.7
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
MMED
Peer Median
Revenue YoY
14.2%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
MMED
Peer Median
MMED Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
15 analysts
- Strong Buy 5 33.3%
- Buy 8 53.3%
- Hold 2 13.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
11 analysts · 2026-07-01
Median
$20.00
Mean
$20.91
← Below all targets
$15.59
Low
$16.00
High
$25.00
Median target
$20.00
+28.3%
Mean target
$20.91
+34.1%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.57%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2026 | $-0.68 | $-0.17 | — |
| June 30, 2026 | $-0.68 | $-0.17 | -0.51% |
| March 31, 2026 | $-0.47 | $0.16 | -0.63% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MDLN | — | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue | $3.10B | $2.71B | |
| Cost of Revenue | $1.42B | $1.19B | |
| Gross Profit | $1.68B | $1.53B | |
| SG&A Expense | $1.18B | $1.08B | |
| Operating Income | $-190M | $-146M | |
| Other Non-op | $1M | $-1M | |
| Pretax Income | $-189M | $-147M | |
| Income Tax | $128M | $52M | |
| Net Income | $-333M | $-213M | |
| EPS (Basic) | $-1.30 | $-0.84 | |
| EPS (Diluted) | $-1.30 | $-0.84 | |
| Shares (Basic) | 256,600,000 | 252,800,000 | |
| Shares (Diluted) | 256,600,000 | 252,800,000 | |
| EBITDA | $-34M | · |
Balance Sheet 24
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Cash & Equivalents | $298M | $11M | |
| Receivables | $200M | $570M | |
| Inventory | $341M | $311M | |
| Other Current Assets | $54M | $48M | |
| Current Assets | $1.35B | $939M | |
| PP&E (Net) | $711M | $706M | |
| PP&E (Gross) | $1.49B | $1.37B | |
| Accum. Depreciation | $781M | $663M | |
| Goodwill | $2.26B | $2.25B | |
| Intangibles | $107M | $132M | |
| Other Non-current Assets | $147M | $150M | |
| Total Assets | $4.63B | $4.20B | |
| Accounts Payable | $163M | $205M | |
| Current Liabilities | $702M | $710M | |
| Capital Leases | $45M | $56M | |
| Other Non-current Liabilities | $317M | $162M | |
| Total Liabilities | $1.02B | $871M | |
| Common Stock | $3M | $0 | |
| Paid-in Capital | $3.74B | $0 | |
| Retained Earnings | $-116M | $0 | |
| AOCI | $-12M | $3M | |
| Stockholders' Equity | $3.61B | $3.33B | |
| Liabilities + Equity | $4.63B | $4.20B | |
| Shares Outstanding | 280,819,988 | 0 |
Cash Flow 12
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| D&A | $156M | $143M | |
| Stock-based Comp | $46M | $41M | |
| Deferred Tax | $-50M | $-2M | |
| Amort. of Intangibles | $26M | $29M | |
| Other Non-cash | $-16M | · | |
| Operating Cash Flow | $-197M | $140M | |
| CapEx | $223M | $193M | |
| Investing Cash Flow | $-233M | $-193M | |
| Financing Cash Flow | $716M | $10M | |
| Net Change in Cash | $287M | $-43M | |
| Taxes Paid | $2M | $0 | |
| Free Cash Flow | $-420M | · |
Profitability 8
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Gross Margin | 54.2% | · | |
| Operating Margin | -6.1% | · | |
| Net Margin | -10.7% | · | |
| Pretax Margin | -6.1% | · | |
| EBITDA Margin | -1.1% | · | |
| ROA | -7.5% | · | |
| ROE | -9.3% | · | |
| ROIC | -8.8% | · |
Liquidity & Solvency 2
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Current Ratio | 1.9 | · | |
| Quick Ratio | 0.7 | · |
Efficiency 3
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Asset Turnover | 0.7 | · | |
| Inventory Turnover | 4.4 | · | |
| Receivables Turnover | 8.1 | · |
Growth Rates 1
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue YoY | 14.2% | 10.0% |
Valuation (TTM) 10
| Metric | Trend | 2026 | 2025 |
|---|---|---|---|
| Revenue TTM | $3.10B | · | |
| Net Income TTM | $-333M | · | |
| Market Cap | $3.71B | · | |
| P/E | -10.2 | · | |
| P/S | 1.2 | · | |
| P/B | 1.0 | · | |
| P / Tangible Book | 3.0 | · | |
| P / Cash Flow | -18.8 | · | |
| P / FCF | -8.8 | · | |
| Earnings Yield | -9.8% | · |
Income Statement 14
| Metric | Trend | Q4 2026 | Q3 2026 | Q4 2025 |
|---|---|---|---|---|
| Revenue | $837M | $790M | $724M | |
| Cost of Revenue | $357M | $428M | $318M | |
| Gross Profit | $480M | $362M | $405M | |
| SG&A Expense | $299M | $309M | $276M | |
| Operating Income | $-93M | $-100M | $-148M | |
| Other Non-op | $1M | $0 | $0 | |
| Pretax Income | $-92M | $-99M | $-148M | |
| Income Tax | $93M | $12M | $21M | |
| Net Income | $-185M | $-119M | $-172M | |
| EPS (Basic) | $-0.71 | $-0.47 | $-0.68 | |
| EPS (Diluted) | $-0.71 | $-0.47 | $-0.68 | |
| Shares (Basic) | 3,786,652 | 252,813,348 | -13,348 | |
| Shares (Diluted) | 3,786,652 | 252,813,348 | -13,348 | |
| EBITDA | · | $-100M | · |
Balance Sheet 24
| Metric | Trend | Q4 2026 | Q3 2026 | Q4 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $298M | $10M | $11M | |
| Receivables | $200M | $653M | $570M | |
| Inventory | $341M | $408M | $311M | |
| Other Current Assets | $54M | $37M | $48M | |
| Current Assets | $1.35B | $1.11B | $939M | |
| PP&E (Net) | $711M | $701M | $706M | |
| PP&E (Gross) | $1.49B | · | $1.37B | |
| Accum. Depreciation | $781M | · | $663M | |
| Goodwill | $2.26B | $2.26B | $2.25B | |
| Intangibles | $107M | $113M | $132M | |
| Other Non-current Assets | $147M | $146M | $150M | |
| Total Assets | $4.63B | $4.34B | $4.20B | |
| Accounts Payable | $163M | $303M | $205M | |
| Current Liabilities | $702M | $696M | $710M | |
| Capital Leases | $45M | $50M | $56M | |
| Other Non-current Liabilities | $317M | $184M | $162M | |
| Total Liabilities | $1.02B | $881M | $871M | |
| Common Stock | $3M | · | $0 | |
| Paid-in Capital | $3.74B | · | $0 | |
| Retained Earnings | $-116M | · | $0 | |
| AOCI | $-12M | $14M | $3M | |
| Stockholders' Equity | $3.61B | $3.46B | $3.33B | |
| Liabilities + Equity | $4.63B | $4.34B | $4.20B | |
| Shares Outstanding | 280,819,988 | · | 0 |
Cash Flow 8
| Metric | Trend | Q4 2026 | Q3 2026 | Q4 2025 |
|---|---|---|---|---|
| D&A | $39M | · | $38M | |
| Stock-based Comp | $8M | · | $9M | |
| Amort. of Intangibles | $6M | $7M | $7M | |
| Operating Cash Flow | $-170M | · | $83M | |
| CapEx | $56M | · | $57M | |
| Investing Cash Flow | $-56M | · | $-57M | |
| Financing Cash Flow | $512M | · | $-25M | |
| Net Change in Cash | $287M | · | $1M |
Profitability 8
| Metric | Trend | Q4 2026 | Q3 2026 | Q4 2025 |
|---|---|---|---|---|
| Gross Margin | · | 45.8% | · | |
| Operating Margin | · | -12.7% | · | |
| Net Margin | · | -15.1% | · | |
| Pretax Margin | · | -12.5% | · | |
| EBITDA Margin | · | -12.7% | · | |
| ROA | · | -5.5% | · | |
| ROE | · | -6.9% | · | |
| ROIC | · | -3.2% | · |
Liquidity & Solvency 2
| Metric | Trend | Q4 2026 | Q3 2026 | Q4 2025 |
|---|---|---|---|---|
| Current Ratio | · | 1.6 | · | |
| Quick Ratio | · | 1.0 | · |
Efficiency 3
| Metric | Trend | Q4 2026 | Q3 2026 | Q4 2025 |
|---|---|---|---|---|
| Asset Turnover | · | 0.4 | · | |
| Inventory Turnover | · | 2.1 | · | |
| Receivables Turnover | · | 2.4 | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2026-04-24 | 2025-04-25 | 2024-04-26 | |
|---|---|---|---|
| Revenue | $3.10B | $2.71B | $2.47B |
| Gross Margin % | 54.2% | — | — |
| Operating Margin % | -6.1% | — | — |
| Net Income | $-333M | $-213M | $-112M |
| Diluted EPS | $-1.30 | $-0.84 | $-0.44 |
Balance Sheet
| 2026-04-24 | 2025-04-25 | 2024-04-26 | |
|---|---|---|---|
| Current Ratio | 1.9 | — | — |
| Quick Ratio | 0.7 | — | — |
Cash Flow
| 2026-04-24 | 2025-04-25 | 2024-04-26 | |
|---|---|---|---|
| Free Cash Flow | $-420M | — | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.